Meds A-Z
Bedinvetmab
Detailed information about Bedinvetmab
Pet Owner Quick Guide
Start here: what this medicine is for, what it does, and when it's usually needed.
Usually used for:
For the control of pain associated with osteoarthritis in dogs.
What it does:
For the control of pain associated with osteoarthritis in dogs.
When it's needed:
For the control of pain associated with osteoarthritis in dogs.
Commonly reported reactions:
- (2 reports)
- (1 reports)
- (1 reports)
What to ask your vet today:
- Is this medicine the right fit for my pet’s current symptoms?
- Which warning signs mean I should call back right away?
- How should I handle missed doses or refusal to take the medicine?
Bedinvetmab
Drug type: Generic ingredient • Branded profile • FDA branded products available
Species: Both
Manufacturer: MSK
Quick Facts
Official label facts first, then secondary summaries. Marketing content is separated below.
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/141562 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source
Warnings / Contraindications
No contraindication summary is linked yet.
No owner-focused warning rows are linked yet.
Adverse Reactions
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Tap or hover a reaction to see what it means in plain language.
Most Reported Reactions
| Reaction | Cases | Species | Serious cases |
|---|---|---|---|
| 2 | Cat, Dog | 0 | |
| 1 | Dog | 1 | |
| 1 | Dog | 1 | |
| 1 | Dog | 1 | |
| 1 | Dog | 1 | |
| 1 | Dog | 1 | |
| 1 | Dog | 1 | |
| 1 | Dog | 1 |
Species coverage: Dog (24) Cat (8)
View detailed reaction table
| Reaction | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Non-serious | - | 1 |
- https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2024-US-016089
Storage & Handling
No storage/handling guidance is linked yet.
Documents
Official label facts are separated from secondary summaries.
Official documents: 3 • Secondary summaries: 0
- FOI Summary oN 141-562 Approved May 5, 2023.pdf · FOI
- N-141562-C-0024-NL-AA_PI.pdf · Labeling
- Librela™ · SPL
No source yet.
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/13959 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/2198 · document · Labeling
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/14131/Librela%E2%84%A2 · document · SPL
Promotional Materials (Marketing)
This content is marketing material and not clinical guidance.
No marketing assets are linked yet.
No source yet.
Technical appendix (vet reference)
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
At a Glance
Quick facts and links to official labeling and safety signals.
- Medication catalog: Source PetWisePlus | Refreshed Feb 12, 2026, 10:44 PM UTC
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Feb 16, 2026, 11:02 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Feb 12, 2026, 10:42 PM UTC
Counseling and Monitoring Highlights
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
Identifiers & Packages
Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.
| Package NDC | Product NDC | Form / Route | Status |
|---|---|---|---|
| 54771-2772-1 | 54771 | - | |
| 54771-2772-2 | 54771 | - | |
| 54771-2778-1 | 54771 | - | |
| 54771-2778-2 | 54771 | - | |
| 54771-2779-1 | 54771 | - | |
| 54771-2779-2 | 54771 | - | |
| 54771-2780-1 | 54771 | - | |
| 54771-2780-2 | 54771 | - | |
| 54771-2781-1 | 54771 | - | |
| 54771-2781-2 | 54771 | - |
Enriched Documents
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
-
N-141562-C-0024-NL-AA_PI.pdf
• Official label • Official
• Feb. 19, 2025
FDA official labeling for application 141562
-
FOI Summary oN 141-562 Approved May 5, 2023.pdf
• FOI summary • Official
• Feb. 19, 2025
FDA FOI summary for application 141562
Data Sources & Revision History
Every non-trivial field is expected to include provenance and update timestamps.
- side_effects: Top reported reactions (openFDA): Death by euthanasia, Lethargy (see also Central nervous system depression in Neurological), Polydipsia, Ataxia, Vomiting, Pol… (Official, 2026-02-12)
- usage: For the control of pain associated with osteoarthritis in dogs. (Official, 2026-02-12)
- side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
FDA Products & Applications (Animal Drugs @ FDA)
Official sponsor/proprietary-name/application-status records linked by active ingredient.
| Product | Sponsor | Application | Status | Published |
|---|---|---|---|---|
|
Librela™
RX
Bedinvetmab
Injectable Solution
• Subcutaneous
|
Zoetis Inc. | NADA 141-562 | Approved | Feb 19, 2025 |
Data source: FDA Animal Drugs @ FDA (public search export).
What It's For (FDA Label Highlights)
Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.
Composition / specifications
For the control of pain associated with osteoarthritis in dogs.
Administer 0.23 mg/pound (0.5 mg/kilogram) body weight monthly by subcutaneous injection.
FDA page: Open in Animal Drugs @ FDA
Official Documents (FDA)
Direct links to FDA-hosted PDFs and SPL packages (when available).
-
Summary
For the control of pain associated with osteoarthritis in dogs
-
Labeling N-141562-C-0024-NL-AA_PI.pdf
- Librela™ (ZIP)
FDA page: Open in Animal Drugs @ FDA
Usage
For the control of pain associated with osteoarthritis in dogs.
Source: FDA Animal Drugs @ FDA • Reference
Contraindications
No approved contraindication text is linked yet. Review FDA label highlights and openFDA safety reports before making treatment decisions.
Side Effects
No approved side-effect narrative is linked yet.
openFDA reaction signals are available for Dog 56 and Cat 8 (view top reported reactions).
Top Reported Reactions (openFDA)
Aggregated reaction terms from FDA openFDA reports (not verified; does not prove causation).
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Adverse Event Case Summaries (openFDA)
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Dog, Retriever - Labrador, Male, 12 year, 34.292 kilogram • Drug: MSK, Subcutaneous, Dose: 20 Milligram per animal • Reactions: Horner's syndrome • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-055778
- Serious AE: No
- Treated For AE: No
- Sex: Male
- Age: 12.00 Year
- Weight: 34.292 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Subcutaneous
- Dose: 20 Milligram per animal
Dog, Mastiff (unspecified), Male, 8 year, 63.503 kilogram • Drug: MSK, Solution, Subcutaneous, Dose: 40 Milligram per animal, Frequency: 1 per month • Reactions: Elevated renal parameters • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-055098
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 8.00 Year
- Weight: 63.503 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Subcutaneous
- Form: Solution
- Dose: 40 Milligram per animal
- Frequency: 1 per month
Dog, ['Terrier (unspecified)', 'Dog (unknown)'], Male, 12 year • Drug: MSK, Solution, Subcutaneous • Reactions: Seizure NOS, Panting, Polydipsia, Not himself/herself, Pain NOS… • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-055277
- Serious AE: Yes
- Treated For AE: No
- Sex: Male
- Age: 12.00 Year
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Subcutaneous
- Form: Solution
Dog, ['Retriever - Labrador', 'Dog (unknown)'], Male, 14 year, 15.876 kilogram • Drug: MSK, Unknown, Dose: 10 Milligram per animal • Reactions: Seizure NOS, Inappropriate urination, Walking difficulty, Urinary incontinence, Swelling NOS… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-056004
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 14.00 Year
- Weight: 15.876 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Dose: 10 Milligram per animal
Dog, ['Dachshund - Standard Long-haired', 'Dog (unknown)'], Male, 12 year, 8.936 kilogram • Drug: MSK, Subcutaneous, Dose: 5 Milligram per animal • Reactions: Fever, Panting, Swollen limb, Localised pain NOS, Paralysis NOS • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-055637
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 12.00 Year
- Weight: 8.936 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Subcutaneous
- Dose: 5 Milligram per animal
Dog, Shepherd Dog - German, Male, 5.8 year, 40.82 kilogram • Drug: MSK, Unknown • Reactions: Sneezing, Listless, Not eating, Reduced responses, Difficulty standing… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-055636
- Serious AE: No
- Treated For AE: Yes
- Sex: Male
- Age: 5.80 Year
- Weight: 40.820 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Cat, Cat (other), Female, 8 year, 4.808 kilogram • Drug: MSK, Solution, Subcutaneous, Dose: 30 Milligram per animal • Reactions: Itching, Prescribing error • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-042435
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Age: 8.00 Year
- Weight: 4.808 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Subcutaneous
- Form: Solution
- Dose: 30 Milligram per animal
Cat, Cat (unknown), Female, 11 year, 4.627 kilogram • Drug: MSK, Parenteral • Reactions: Itching • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-024035
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Age: 11.00 Year
- Weight: 4.627 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Parenteral
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Overdose Information
No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.
Storage & Handling
No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.
Share Your Thoughts
Let others know your experience or advice regarding this medication.
This medication has not been reviewed by a veterinarian yet.